DayTwo, an Israeli startup focused on delivering insights to consumers based on their gut microbiome, has raised $12 million from an impressive suite of investors including Johnson & Johnson Innovation and the Mayo Clinic. Seventure Partners' Health for Life Capital Fund also contributed along with private investors including cofounder Marius Nacht.
The startup, which has raised $17 million...
Researchers at California NanoSystems Institute at UCLA, Stockholm University and Uppsala University are working on a smartphone-based microscope in hopes of developing a cost-effective and accessible way for DNA sequencing and genetic mutation analysis.
As described in a recently published article in the journal Nature Communications, the researchers used a 3D printer to produce a lightweight...
San Francisco-based uBiome, which makes a direct-to-consumer microbial genomic testing kit, has closed on a $22 million Series B funding round, led by 8VC with additional funding from Slow Ventures, Stanford’s StartX Fund and various angel investors. The funding will be used to deploy uBiome’s new testing kit, SmartGut, a sequencing-based clinical microbiome screening test.
With an at-home...
